HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N,N- dimethyl- 7- (4- (2- (pyridin- 2- yl)ethyl)piperazin- 1- yl)benzofuran- 2- carboxamide

an antagonist of both 5-HT(1A) and 5-HT(1B) receptors; structure in first source

Also Known As:

AZD3676

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - N,N-dimethyl-7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxamide: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzofurans: 26
      - N,N-dimethyl-7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxamide: 1

Experts

1.	Afzelius, Lovisa: 1 article (01/2016)
2.	Ahlgren, Charlotte: 1 article (01/2016)
3.	Farde, Lars: 1 article (01/2016)
4.	Gruber, Susanne: 1 article (01/2016)
5.	Halldin, Christer: 1 article (01/2016)
6.	Jerning, Eva: 1 article (01/2016)
7.	Johnström, Peter: 1 article (01/2016)
8.	Juréus, Anders: 1 article (01/2016)
9.	Malmborg, Jonas: 1 article (01/2016)
10.	Schou, Magnus: 1 article (01/2016)

Related Diseases

1.	Cognitive Dysfunction 01/01/2016 - "AZD3676 [N,N-dimethyl-7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl) benzofuran-2-carboxamide] is a novel combined serotonin (5-hydroxytryptamine) 5-HT1A and 5-HT1B receptor antagonist that was developed for the treatment of cognitive impairment in Alzheimer's disease. "
2.	Alzheimer Disease (Alzheimer's Disease) 01/01/2016 - "AZD3676 [N,N-dimethyl-7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl) benzofuran-2-carboxamide] is a novel combined serotonin (5-hydroxytryptamine) 5-HT1A and 5-HT1B receptor antagonist that was developed for the treatment of cognitive impairment in Alzheimer's disease. "

Related Drugs and Biologics

1.	5-HT1B Serotonin Receptor
2.	Serotonin (5 Hydroxytryptamine)
3.	benzofuran